Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 465

1.

Primary Care 2030: Creating an Enabling Ecosystem for Disruptive Primary Care Models to Achieve Universal Health Coverage in Low- and Middle-Income Countries.

Schwarz D, Duong D, Adam C, Awoonor-Williams JK, Back D, Bang A, Bang R, Beebe M, Bhatt S, Campbell J, Conteh M, Dimitrova D, Dimovska D, Dossou JP, Evans T, Gadir M, Islam K, Kasyaba R, Kumar P, Levy C, Oanh TM, Monsef N, Oh J, Otoo N, Palazuelos D, Poh A, Sinha S, Smith C, Stewart B, Thomas C, Tritter B, Varnum P, Weilnau T, Ellner A.

Ann Glob Health. 2020 Feb 3;86(1):9. doi: 10.5334/aogh.2471.

2.

Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile.

Hoffman-Censits J, Choi W, Pal S, Trabulsi E, Kelly WK, Hahn NM, McConkey D, Comperat E, Matoso A, Cussenot O, Cancel-Tassin G, Fong MHY, Ross J, Madison R, Ali S.

Eur Urol Oncol. 2020 Feb 12. pii: S2588-9311(19)30168-3. doi: 10.1016/j.euo.2019.12.002. [Epub ahead of print]

PMID:
32061548
3.

Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis.

Spring LM, Fell G, Arfe A, Sharma C, Greenup RA, Reynolds KL, Smith BL, Alexander BM, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A.

Clin Cancer Res. 2020 Feb 11. pii: clincanres.3492.2019. doi: 10.1158/1078-0432.CCR-19-3492. [Epub ahead of print]

PMID:
32046998
4.

Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.

Valiakhmetova A, Gorelyshev S, Konovalov A, Trunin Y, Savateev A, Kram DE, Severson E, Hemmerich A, Edgerly C, Duncan D, Britt N, Huang RSP, Elvin J, Miller V, Ross JS, Gay L, McCorkle J, Rankin A, Erlich RL, Chudnovsky Y, Ramkissoon SH.

Oncologist. 2020 Feb;25(2):e198-e202. doi: 10.1634/theoncologist.2019-0603. Epub 2019 Oct 16.

5.
6.

Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.

Febbo PG, Martin AM, Scher HI, Barrett JC, Beaver JA, Beresford PJ, Blumenthal GM, Bramlett K, Compton C, Dittamore R, Eberhard DA, Edelstein D, Godsey J, Gruen A, Hanlon SE, Hicks J, Hovelson D, Hullings M, Johann D, Johnson J, Kolatkar A, Kuhn P, Levine R, Martini JF, Miller DP, Moore C, Moy B, Pathak A, Philip R, Reese D, Royalty W, Ryder M, Sakul H, Salvatore LM, Schade A, Silvestro A, Simmons JK, Simons J, Singh Bhan S, Smalley MD, Somiari SB, Talasaz A, Tewari M, Tseng HR, Vinson J, Wells W, Welsh A, Grossman RL, Lee JSH, Leiman LC.

Clin Pharmacol Ther. 2020 Feb 4. doi: 10.1002/cpt.1747. [Epub ahead of print] No abstract available.

PMID:
32017048
7.

Undifferentiated small round cell sarcoma in a young male: a case report.

Ricker CA, Berlow NE, Crawford KA, Georgopapadakos T, Huelskamp AN, Woods AD, Dhimolea E, Ramkissoon SH, Spunt SL, Rudzinski ER, Keller C.

Cold Spring Harb Mol Case Stud. 2020 Feb 3;6(1). pii: a004812. doi: 10.1101/mcs.a004812. Print 2020 Feb.

8.

Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.

Mobark NA, Alharbi M, Alhabeeb L, AlMubarak L, Alaljelaify R, AlSaeed M, Almutairi A, Alqubaishi F, Ahmad M, Al-Banyan A, Alotabi FE, Barakeh D, AlZahrani M, Al-Khalidi H, Ajlan A, Ramkissoon LA, Ramkissoon SH, Abedalthagafi M.

PLoS One. 2020 Jan 29;15(1):e0228356. doi: 10.1371/journal.pone.0228356. eCollection 2020.

9.

Clinicopathologic Characteristics of BRG1-Deficient Non-Small Cell Lung Cancer.

Dagogo-Jack I, Schrock AB, Kem M, Jessop N, Lee J, Ali SM, Ross JS, Lennerz JK, Shaw AT, Mino-Kenudson M.

J Thorac Oncol. 2020 Jan 24. pii: S1556-0864(20)30023-X. doi: 10.1016/j.jtho.2020.01.002. [Epub ahead of print]

PMID:
31988001
10.

Urothelial Cancer Harbors EGFR and HER2 Amplifications and Exon 20 Insertions.

Madison RW, Gupta SV, Elamin YY, Lin DI, Pal SK, Necchi A, Miller VA, Ross JS, Chung JH, Alexander BM, Schrock AB, Heymach JV, Reddy P, Ali SM.

BJU Int. 2020 Jan 27. doi: 10.1111/bju.15006. [Epub ahead of print]

PMID:
31985116
11.

Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.

Necchi A, Madison R, Raggi D, Jacob JM, Bratslavsky G, Shapiro O, Elvin JA, Vergilio JA, Killian JK, Ngo N, Ramkissoon S, Severson E, Hemmerich AC, Huang R, Ali SM, Chung JH, Reddy P, Miller VA, Schrock AB, Gay LM, Alexander BM, Grivas P, Ross JS.

Eur Urol. 2020 Jan 17. pii: S0302-2838(20)30003-8. doi: 10.1016/j.eururo.2020.01.003. [Epub ahead of print]

PMID:
31959546
12.

Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.

Connor YD, Miao D, Lin DI, Hayne C, Howitt BE, Dalrymple JL, DeLeonardis KR, Hacker MR, Esselen KM, Shea M.

Gynecol Oncol. 2019 Dec 21. pii: S0090-8258(19)31618-X. doi: 10.1016/j.ygyno.2019.10.031. [Epub ahead of print]

PMID:
31954538
13.

Squamous Transformation of Prostate Adenocarcinoma: A Report of Two Cases With Genomic Profiling.

Dizman N, Salgia M, Ali SM, Wu H, Arvanitis L, Chung JH, Pal SK.

Clin Genitourin Cancer. 2019 Dec 4. pii: S1558-7673(19)30371-4. doi: 10.1016/j.clgc.2019.11.020. [Epub ahead of print] No abstract available.

PMID:
31882336
14.

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.

Necchi A, Bandini M, Calareso G, Raggi D, Pederzoli F, Farè E, Colecchia M, Marandino L, Bianchi M, Gallina A, Colombo R, Fossati N, Gandaglia G, Capitanio U, Dehò F, Giannatempo P, Lucianò R, Salonia A, Madison R, Ali SM, Chung JH, Ross JS, Briganti A, Montorsi F, De Cobelli F, Messina A.

Eur Urol. 2019 Dec 24. pii: S0302-2838(19)30960-1. doi: 10.1016/j.eururo.2019.12.016. [Epub ahead of print]

PMID:
31882281
15.

S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.

Yuan W, Goldstein LD, Durinck S, Chen YJ, Nguyen TT, Kljavin NM, Sokol ES, Stawiski EW, Haley B, Ziai J, Modrusan Z, Seshagiri S.

Breast Cancer Res. 2019 Dec 27;21(1):152. doi: 10.1186/s13058-019-1238-5.

16.

Comparison Between Integrated Genomic DNA/RNA Profiling and Fluorescence In Situ Hybridization in the Detection of MYC, BCL-2, and BCL-6 Gene Rearrangements in Large B-Cell Lymphomas.

Cassidy DP, Chapman JR, Lopez R, White K, Fan YS, Casas C, Severson EA, Vega F.

Am J Clin Pathol. 2020 Feb 8;153(3):353-359. doi: 10.1093/ajcp/aqz172.

PMID:
31872861
17.

Endometrioid Tubal Intraepithelial Neoplasia (E-TIN) of the Fallopian Tube: A Case Series.

Hecht JL, Lin DI, Garrett L.

Int J Gynecol Pathol. 2019 Dec 18. doi: 10.1097/PGP.0000000000000650. [Epub ahead of print]

PMID:
31855954
18.

A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Reported in ALL.

Mejia Saldarriaga M, Steinberg A, Severson EA, Binder A.

Front Oncol. 2019 Dec 3;9:1303. doi: 10.3389/fonc.2019.01303. eCollection 2019.

19.

Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes.

Demoret B, Gregg J, Liebner DA, Tinoco G, Lenobel S, Chen JL.

Cancers (Basel). 2019 Nov 21;11(12). pii: E1829. doi: 10.3390/cancers11121829.

20.

iTRAQ-based proteomic analysis of Mycoplasma bovis NM-28 strain from two generations for vaccine screening.

Wang Y, Zhou Y, Zhang J, Wang X, Lv T, Shi X, Huang H, Bai F, Wu Q, Hao Y.

Vaccine. 2020 Jan 16;38(3):549-561. doi: 10.1016/j.vaccine.2019.10.061. Epub 2019 Nov 15.

PMID:
31740094

Supplemental Content

Loading ...
Support Center